Boosting Protein Research with New Mass Spectrometry Technology

Researchers at the Proteomics Technology Hub of the Institute of Molecular Biotechnology Austria (IMBA), Gregor Mendel Institute (GMI), and Research Institute of Molecular Pathology (IMP) at the Vienna BioCenter, have developed a new cross-linking mass spectrometry workflow that improves the detection of protein interactions. The team identified over 40% more protein crosslinks than with previous instruments, revealing interactions that were previously undetectable. The optimized method enhances structural studies and strengthens the Vienna BioCenter’s high-sensitivity proteomics technology.

Read the full article at the Vienna BioCenter's website.